Search - tctmd.com

Displaying 121 - 140 of 421

Sort: Relevancy | Date

Presentation

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Presenter: James P. Howard

January 11, 2016

Presentation

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Presenter: G. Qian

December 08, 2015

Presentation

Representation of Patients With Kidney Disease in Trials of CVD Interventions

Presenter: Ioannis Konstantinidis

December 02, 2015

Presentation

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

Presenter: M. Donahue

September 25, 2015

Presentation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Presenter: Marco Barbanti

September 21, 2015

Presentation

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Presenter: Johan Bosmans

July 14, 2015

Presentation

Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI

Presenter: J. Parsh

June 26, 2015

Presentation CCVVC 2015

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Presenter: Mark Wholey

June 17, 2015

Presentation

Case Presentation: Severe Renal Disease and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Philippe Genereux

June 04, 2015

Presentation Fellows 2015

Renal Artery Interventions: Current State of the Field

Presenter: William A. Gray, Duane S. Pinto

May 17, 2015

Presentation ARCH 2015

Renal Denervaton ~ Early Trials

Presenter: Rothstein Marcos

April 11, 2015

Presentation ARCH 2015

Renal Artery Revascularization

Presenter: Marc A. Sintek

April 09, 2015

Presentation CADECI 2015

Donde estamos en la denervación renal, después del estudio SYMPLICITY 3

Presenter: Dr. Juan Gaspar

February 19, 2015

Presentation ISET 2015

Is There a Role for Renal Stenting in 2015?

Presenter: Jeffrey W. Olin

February 03, 2015

Presentation ISET 2015

Is There Hope for Renal Denervation?

Presenter: Ron Waksman

February 01, 2015

Presentation ISET 2015

Current Challenge and Directions in Renal Denervation

Presenter: Marty B. Leon

February 01, 2015

Presentation ISET 2015

Endovascular Therapy in the Management of Hypertension

Presenter: Barry T. Katzen

January 30, 2015

Presentation

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Presenter: Nissen Bonde

December 08, 2014

Presentation

Randomized Comparison of Renal Denervation vs Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension

Presenter: J?n Rosa

December 04, 2014

Presentation Cardiovascular Interventions 2014

Show Me The Data: Key Clinical Trials in 2014

Presenter: David P. Faxon

October 23, 2014

Advertisement

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Representation of Patients With Kidney Disease in Trials of CVD Interventions

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Case Presentation: Severe Renal Disease and TAVR

Renal Artery Interventions: Current State of the Field

Renal Denervaton ~ Early Trials

Renal Artery Revascularization

Donde estamos en la denervación renal, después del estudio SYMPLICITY 3

Is There a Role for Renal Stenting in 2015?

Is There Hope for Renal Denervation?

Current Challenge and Directions in Renal Denervation

Endovascular Therapy in the Management of Hypertension

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Randomized Comparison of Renal Denervation vs Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension

Show Me The Data: Key Clinical Trials in 2014

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content